Clark Tedford
Clark Tedford is President and CEO at Solentix BioSciences, Inc. He previously served as Vice President and Chief Science Officer at PhotoThera, Vice President of Research at Omeros, and Executive Vice President of R&D at Gliatech Inc.
Alcon Acquires LumiThera, Developer of FDA-Authorized Valeda Vision Device for Dry AMD
Alcon has acquired LumiThera, the developer of the FDA-authorized Valeda Light Delivery System, a device that improves vision in dry age-related macular degeneration patients using photobiomodulation. LumiThera will spin off its diagnostic business into a new company named OpZira, Inc.
LumiThera raises $14M to complete LIGHTSITE III trial and pursue U.S. clearance for Valeda
LumiThera, a Poulsbo, Wash. medical device startup, raised $14 million to finish enrollment in its LIGHTSITE III U.S. trial and seek U.S. regulatory clearance for Valeda, a photobiomodulation device for dry age-related macular degeneration already approved in the EU.
LumiThera raises $1.15M to advance Valeda photobiomodulation device for dry AMD, in U.S. trials and EU‑approved
LumiThera raised $1.15 million to advance its Valeda Light Delivery System, a photobiomodulation device aimed at improving and slowing vision loss in patients with dry age-related macular degeneration that is in U.S. clinical trials and approved for sale in the EU. The Poulsbo, Washington startup, co‑founded and led by CEO Clark Tedford, lists investors including Keiretsu Forum Northwest and executives with medical-device experience on its leadership team.
Organizations
See all 4-
Solentix BioSciences, Inc. President and CEO 2013–present · current
-
PhotoThera Vice President, Chief Science Officer 2011–2012 · past
-
Omeros Vice President, Research 2003–2011 · past
Education
-
University of Iowa Doctor of Philosophy (Ph.D.), Pharmacology and Toxicology · 1977–1986
-
University of Iowa Biochemistry · 1977–1981